Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea flag South Korea · Delayed Price · Currency is KRW
972.00
-7.00 (-0.72%)
At close: Jun 5, 2026

Abpro Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,5113,89915,49518,85616,95153,961
Short-Term Investments
1,4861,1836,163944.31796.04430.25
Trading Asset Securities
---68.364,087-
Cash & Short-Term Investments
5,9975,08221,65719,86921,83454,391
Cash Growth
-67.13%-76.53%9.00%-9.00%-59.86%76.11%
Accounts Receivable
6,3283,75310,0963,9943,2262,781
Other Receivables
4,493549.82880.071,0393251,412
Receivables
11,1996,95012,2617,8684,4514,193
Inventory
14,08013,56313,53416,43218,61015,189
Prepaid Expenses
213.33358.8598.4837.4340.62520.3
Other Current Assets
552.071,039930.48598.36857.227,610
Total Current Assets
32,04126,99348,98144,80445,79381,903
Property, Plant & Equipment
22,18822,56921,57422,57923,09924,170
Long-Term Investments
3,5953,40943,49556,41379,77257,308
Goodwill
9,0149,01413,4968,004--
Other Intangible Assets
3,0763,1533,3383,4822,3883,621
Long-Term Accounts Receivable
-19.43112.81252--
Long-Term Deferred Tax Assets
825.12820.75575.98125.75--
Other Long-Term Assets
8,4248,7709,3316,4505,563848.94
Total Assets
79,18874,777141,263142,110156,646167,884
Accounts Payable
3,1922,0206,8552,1271,5592,911
Accrued Expenses
743.54655.88652.56755.34733.9478.75
Short-Term Debt
2,4622,5358,7359,24910,19621,013
Current Portion of Long-Term Debt
194.25188.9971.3333.16--
Current Portion of Leases
392.23492.43383.92367.48303.02214.43
Current Income Taxes Payable
---7.35--
Other Current Liabilities
3,1722,4973,4185,0853,2175,143
Total Current Liabilities
10,1568,39021,01517,92516,00929,760
Long-Term Debt
11,87211,91411,5061,294--
Long-Term Leases
206.34373.72456.43550.76441.24582.9
Long-Term Deferred Tax Liabilities
--213.32---
Other Long-Term Liabilities
70.1670.1659.75-000
Total Liabilities
22,30420,74833,25119,76916,45030,343
Common Stock
16,288142,345142,345142,345136,845130,102
Additional Paid-In Capital
91,72189,78689,78689,11687,28885,635
Retained Earnings
-47,301-177,484-128,564-112,935-87,193-79,070
Treasury Stock
-2.9-2.9-2.9-2.9-2.9-2.9
Comprehensive Income & Other
-3,821-614.974,4483,8173,259876.8
Total Common Equity
56,88554,029108,012122,340140,196137,541
Shareholders' Equity
56,88554,029108,012122,340140,196137,541
Total Liabilities & Equity
79,18874,777141,263142,110156,646167,884
Total Debt
15,12715,50422,05311,79410,94021,811
Net Cash (Debt)
-9,130-10,422-395.598,07510,89332,581
Net Cash Growth
----25.88%-66.56%67.16%
Net Cash Per Share
-320.58-366.10-13.57290.17406.051208.38
Filing Date Shares Outstanding
28.5128.4728.4728.4727.3726.02
Total Common Shares Outstanding
28.5128.4728.4728.4727.3726.02
Working Capital
21,88618,60327,96626,87929,78352,143
Book Value Per Share
1995.211897.833794.054297.355122.465285.92
Tangible Book Value
44,79541,86291,178110,854137,808133,920
Tangible Book Value Per Share
1571.171470.463202.743893.895035.225146.75
Land
11,74011,74011,74010,00010,00010,000
Buildings
11,95611,6319,87318,48018,49418,607
Machinery
5,7405,5885,4996,9967,3527,218
Construction In Progress
--14.55500-145.23